Csilla Ari Selected Research

Salts

11/2021	Adenosine Receptors Modulate the Exogenous Ketogenic Supplement-Evoked Alleviating Effect on Lipopolysaccharide-Generated Increase in Absence Epileptic Activity in WAG/Rij Rats.
6/2021	Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases.
1/2021	Enhancement of Ketone Supplements-Evoked Effect on Absence Epileptic Activity by Co-Administration of Uridine in Wistar Albino Glaxo Rijswijk Rats.
8/2020	Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models.
1/2019	Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Csilla Ari Research Topics

Disease

12	Ketosis 10/2023 - 05/2013
5	Body Weight (Weight, Body) 11/2021 - 01/2014
4	Epilepsy (Aura) 01/2021 - 01/2017
3	Absence Epilepsy (Childhood Absence Epilepsy) 01/2021 - 01/2019
2	Seizures (Absence Seizure) 01/2019 - 05/2013
1	Anxiety Disorders (Anxiety Disorder) 10/2023
1	Glut1 Deficiency Syndrome 08/2020
1	Unconsciousness (Loss of Consciousness) 01/2020
1	Inflammation (Inflammations) 10/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Insulin Resistance 01/2016
1	Hyperinsulinism (Hyperinsulinemia) 01/2016
1	Obesity 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 08/2014
1	Disease Progression 01/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2014
1	Drug Resistant Epilepsy 05/2013
1	Neoplasms (Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

15	KetonesIBA 10/2023 - 01/2013
8	Blood Glucose (Blood Sugar)IBA 11/2021 - 01/2013
7	EstersIBA 11/2021 - 05/2013
5	SaltsIBA 11/2021 - 01/2019
5	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 11/2021 - 01/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2013
3	Oxygen (Dioxygen)IBA 01/2019 - 01/2013
2	LipopolysaccharidesIBA 11/2021 - 01/2019
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2020
2	Adenosine A1 ReceptorIBA 01/2020 - 01/2017
2	Isoflurane FDA LinkGeneric 01/2020 - 01/2018
2	acetoacetic acid (acetoacetate)IBA 01/2019 - 05/2013
2	CarbohydratesIBA 01/2016 - 01/2013
1	Adenosine (Adenocard)FDA LinkGeneric 11/2021
1	pyrimidineIBA 11/2021
1	1,3-dipropyl-8-cyclopentylxanthineIBA 11/2021
1	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 11/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 11/2021
1	Histones (Histone)IBA 06/2021
1	AntioxidantsIBA 06/2021
1	RNA (Ribonucleic Acid)IBA 06/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2021
1	Neuroprotective AgentsIBA 06/2021
1	UridineIBA 01/2021
1	Ketone BodiesIBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Amyloid beta-PeptidesIBA 08/2014
1	Glutamic Acid (Glutamate)FDA Link 01/2014
1	AcetoneIBA 05/2013
1	Firefly LuciferasesIBA 01/2013

Therapy/Procedure

7	Ketogenic Diet 08/2020 - 01/2013
2	Anesthesia 01/2020 - 01/2018
2	Diet Therapy (Therapy, Diet) 01/2020 - 01/2016
2	Hyperbaric Oxygenation 01/2019 - 01/2013
2	Oral Administration 01/2016 - 05/2013
2	Therapeutics 01/2014 - 01/2013
1	Aftercare (After-Treatment) 01/2018